Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:MXCT
일자시간출처헤드라인심볼기업
2024/09/2101:02RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
2024/09/1618:33Alliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
2024/09/1615:00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
2024/09/1615:00RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
2024/09/0701:07RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
2024/09/0619:33RNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
2024/09/0323:38RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2024/08/2918:06RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
2024/08/0722:10Alliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
2024/08/0715:05RNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
2024/08/0715:00RNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
2024/08/0200:31RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2024/07/3115:00RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
2024/07/1017:15RNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
2024/07/0917:14RNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
2024/07/0315:00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
2024/07/0219:18RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
2024/07/0215:00RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2024/06/2722:34RNS Regulatory NewsMaxCyte, Inc. Publication of Annual ReportLSE:MXCTMaxcyte Inc
2024/06/1415:00RNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
2024/06/1215:00RNS Regulatory NewsMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
2024/06/1119:10Alliance NewsAlliance NewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 sharesLSE:MXCTMaxcyte Inc
2024/06/1115:00RNS Regulatory NewsMaxCyte, Inc. PDMR DealingLSE:MXCTMaxcyte Inc
2024/06/0323:22RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
2024/05/2921:05RNS Regulatory NewsMaxCyte, Inc. Participation in Upcoming Investor ConferenceLSE:MXCTMaxcyte Inc
2024/05/2305:51Alliance NewsAlliance NewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech supplyLSE:MXCTMaxcyte Inc
2024/05/2221:05RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
2024/05/2015:00RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
2024/05/1422:55RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
2024/05/0817:46Alliance NewsAlliance NewsMaxCyte shares rise amid double-digit revenue increaseLSE:MXCTMaxcyte Inc
 검색 관련기사 보기:LSE:MXCT